belapectin — NDA/BLA submission
Q3 2026
We are working diligently and expect to submit the registrational Phase 3 protocol in the third quarter,Source filing
GALT biotech catalysts & pipeline
GALECTIN THERAPEUTICS INC · Data as of 2026-09-08
GALECTIN THERAPEUTICS INC · Data as of 2026-09-08
Q3 2026
We are working diligently and expect to submit the registrational Phase 3 protocol in the third quarter,Source filing